Biotech | August 20, 2021
Enzene Biosciences obtains DCGI approval for Romiplostim biosimilar
It is the only biopharmaceutical company in India to offer all three dosage strengths of the drug (125mcg, 250mcg, and 500mcg)
It is the only biopharmaceutical company in India to offer all three dosage strengths of the drug (125mcg, 250mcg, and 500mcg)
It’s an AB-rated generic therapeutic version of Durezol
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
Filing for WHO Emergency Use Authorisation this month
India business contributes to a stellar performance
MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery
It had an estimated market size of US $ 32 million as of June 2021
Total income grew in the quarter
Apollo hospital-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital Jaipur have deployed this solution
Proceeds from the IPO will be used for the expansion of the Dehradun facility.
Subscribe To Our Newsletter & Stay Updated
